(Approval lapsed) Lidocaine Hydrochloride Injection 1% (50mg/5mL) ampoules (Hameln, UK)
Section 19A approved medicine
(Approval lapsed) Lidocaine Hydrochloride Injection 1% (50mg/5mL) ampoules (Hameln, UK)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
Bridgewest LIDOCAINE INJECTION 1% 50 mg/5 mL solution for injection ampoule - ARTG 49296
Indication(s)
- Treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.
- Lidocaine is indicated for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks.
Images
